In Brief: Endocare/Aloka Ultrasound
This article was originally published in The Gray Sheet
Endocare/Aloka Ultrasound: Firms enter strategic alliance for the U.S. marketing of Endocare's Cryocare cryotherapy system for treating prostate cancer. Under the agreement, Aloka will help train users of the Cryocare system in the proper use of ultrasound with cryotherapy. In exchange, Aloka gains rights to sell its ultrasound systems to Endocare's customer base. "Having the strength of a premier ultrasound company like Aloka helping us market cryotherapy will result in a more complete presentation to our customers," Endocare says. The Cryocare system, which uses an argon gas-based cryogen, was cleared by FDA in mid-1995 and formally introduced by Endocare at the recent American Urological Association annual meeting in Orlando...
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.